Biology Category
Pharmaceutical drug discovery from targets to clinical candidates.
Welcome to the Drug Discovery category of this site. Here you will find clear, detailed articles covering key topics related to Drug Discovery.
A detailed guide to admet profiling in early drug development. Covers key mechanisms, biological significance, and clinical relevance.
A detailed guide to allosteric modulator discovery strategies. Covers key mechanisms, biological significance, and clinical relevance.
A detailed guide to antibody drug conjugate linker technology. Covers key mechanisms, biological significance, and clinical relevance.
A detailed guide to binding affinity measurement techniques. Covers key mechanisms, biological significance, and clinical relevance.
A detailed guide to bioisostere replacement in lead optimization. Covers key mechanisms, biological significance, and clinical relevance.
A detailed guide to bispecific antibody engineering for therapy. Covers key mechanisms, biological significance, and clinical relevance.
A detailed guide to candidate selection criteria for clinical development. Covers key mechanisms, biological significance, and clinical relevance.
A detailed guide to combinatorial chemistry and library synthesis. Covers key mechanisms, biological significance, and clinical relevance.
A detailed guide to covalent inhibitor design and targeting. Covers key mechanisms, biological significance, and clinical relevance.
A detailed guide to cryogenic electron microscopy in structure guided design. Covers key mechanisms, biological significance, and clinical relevance.
A detailed guide to cytochrome p450 inhibition screening panels. Covers key mechanisms, biological significance, and clinical relevance.
A detailed guide to dna encoded chemical libraries. Covers key mechanisms, biological significance, and clinical relevance.
A detailed guide to dose response curves in lead characterization. Covers key mechanisms, biological significance, and clinical relevance.
A detailed guide to drug discovery pipeline from target to market. Covers key mechanisms, biological significance, and clinical relevance.
A detailed guide to drug drug interaction prediction in discovery. Covers key mechanisms, biological significance, and clinical relevance.
A detailed guide to druggability assessment of protein targets. Covers key mechanisms, biological significance, and clinical relevance.
A detailed guide to enzyme inhibitor development for disease targets. Covers key mechanisms, biological significance, and clinical relevance.
A detailed guide to fragment based lead discovery approaches. Covers key mechanisms, biological significance, and clinical relevance.
A detailed guide to free energy perturbation for binding prediction. Covers key mechanisms, biological significance, and clinical relevance.
A detailed guide to high throughput screening assay design. Covers key mechanisms, biological significance, and clinical relevance.
A detailed guide to hit identification from chemical libraries. Covers key mechanisms, biological significance, and clinical relevance.
A detailed guide to in silico toxicity prediction methods. Covers key mechanisms, biological significance, and clinical relevance.
A detailed guide to ion channel drug development challenges. Covers key mechanisms, biological significance, and clinical relevance.
A detailed guide to kinase inhibitor selectivity profiling. Covers key mechanisms, biological significance, and clinical relevance.
A detailed guide to kinetics of drug target association and dissociation. Covers key mechanisms, biological significance, and clinical relevance.
A detailed guide to lead optimization strategies in medicinal chemistry. Covers key mechanisms, biological significance, and clinical relevance.
A detailed guide to ligand based virtual screening methods. Covers key mechanisms, biological significance, and clinical relevance.
A detailed guide to lipinski rule of five and oral bioavailability. Covers key mechanisms, biological significance, and clinical relevance.
A detailed guide to medicinal chemistry scaling from lead to candidate. Covers key mechanisms, biological significance, and clinical relevance.
A detailed guide to metabolic stability and drug clearance studies. Covers key mechanisms, biological significance, and clinical relevance.
A detailed guide to molecular docking and pose prediction. Covers key mechanisms, biological significance, and clinical relevance.
A detailed guide to molecular dynamics simulations in binding studies. Covers key mechanisms, biological significance, and clinical relevance.
A detailed guide to natural product libraries in screening. Covers key mechanisms, biological significance, and clinical relevance.
A detailed guide to off target activity profiling and selectivity. Covers key mechanisms, biological significance, and clinical relevance.
A detailed guide to oligonucleotide therapeutics design considerations. Covers key mechanisms, biological significance, and clinical relevance.
A detailed guide to peptide drug development and stability challenges. Covers key mechanisms, biological significance, and clinical relevance.
A detailed guide to permeability assessment across biological barriers. Covers key mechanisms, biological significance, and clinical relevance.
A detailed guide to pharmacophore modeling and compound mapping. Covers key mechanisms, biological significance, and clinical relevance.
A detailed guide to phenotypic screening in drug discovery. Covers key mechanisms, biological significance, and clinical relevance.
A detailed guide to physicochemical properties and drug likeness. Covers key mechanisms, biological significance, and clinical relevance.
A detailed guide to prodrug design for targeted drug activation. Covers key mechanisms, biological significance, and clinical relevance.
A detailed guide to protac degraders and targeted protein degradation. Covers key mechanisms, biological significance, and clinical relevance.
A detailed guide to protein crystallography in fragment to lead expansion. Covers key mechanisms, biological significance, and clinical relevance.
A detailed guide to quantitative structure activity relationship models. Covers key mechanisms, biological significance, and clinical relevance.
A detailed guide to receptor antagonist discovery for gpcr targets. Covers key mechanisms, biological significance, and clinical relevance.
A detailed guide to solubility enhancement strategies for poorly soluble drugs. Covers key mechanisms, biological significance, and clinical relevance.
A detailed guide to solvent mapping and hydration site analysis. Covers key mechanisms, biological significance, and clinical relevance.
A detailed guide to structure activity relationship studies in drug design. Covers key mechanisms, biological significance, and clinical relevance.
A detailed guide to target identification and validation methods. Covers key mechanisms, biological significance, and clinical relevance.
A detailed guide to x ray co crystal structures in lead design. Covers key mechanisms, biological significance, and clinical relevance.
